chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea, Headache, Nausea, Vomiting
Clinical narrative: diarrhea; vomiting; nausea; horrible headache; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (diarrhea), VOMITING (vomiting), NAUSEA (nausea) and HEADACHE (horrible headache) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 31-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 31-Jan-2021, the patient experienced DIARRHOEA (diarrhea), VOMITING (vomiting), NAUSEA (nausea) and HEADACHE (horrible headache). On 31-Jan-2021, DIARRHOEA (diarrhea), VOMITING (vomiting), NAUSEA (nausea) and HEADACHE (horrible headache) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported. No treatment related information has been reported.
Sex: M
Vaccine: COVID19
Symptoms: COVID-19
Clinical narrative: Positive COVID-19; This spontaneous case was reported by a health care professional and describes the occurrence of COVID-19 (Positive COVID-19) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037K20A) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Feb-2021, the patient experienced COVID-19 (Positive COVID-19). At the time of the report, COVID-19 (Positive COVID-19) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were reported. No treatment related information has been reported.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Eye swelling, Headache, Lymphadenopathy, Myalgia
Clinical narrative: swollen right eye; warm; red spot; egg-sized lymph node on the right side of her neck where the clavicle bone is located; hard; headache; Patient says they are feeling achiness; chills; This spontaneous case was reported by a consumer and describes the occurrence of EYE SWELLING (swollen right eye), VACCINATION SITE WARMTH (warm), VACCINATION SITE ERYTHEMA (red spot), LYMPHADENOPATHY (egg-sized lymph node on the right side of her neck where the clavicle bone is located) and VACCINATION SITE INDURATION (hard) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 02-Feb-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Feb-2021, the patient experienced HEADACHE (headache), MYALGIA (Patient says they are feeling achiness) and CHILLS (chills). On 03-Feb-2021, the patient experienced EYE SWELLING (swollen right eye), VACCINATION SITE WARMTH (warm), VACCINATION SITE ERYTHEMA (red spot), LYMPHADENOPATHY (egg-sized lymph node on the right side of her neck where the clavicle bone is located) and VACCINATION SITE INDURATION (hard). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency and CETIRIZINE HYDROCHLORIDE (ZYRTEC [CETIRIZINE HYDROCHLORIDE]) at an unspecified dose and frequency. At the time of the report, EYE SWELLING (swollen right eye), VACCINATION SITE WARMTH (warm), VACCINATION SITE ERYTHEMA (red spot), LYMPHADENOPATHY (egg-sized lymph node on the right side of her neck where the clavicle bone is located), VACCINATION SITE INDURATION (hard), HEADACHE (headache), MYALGIA (Patient says they are feeling achiness) and CHILLS (chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site induration, Vaccination site warmth
Clinical narrative: swollen right eye; warm; red spot; egg-sized lymph node on the right side of her neck where the clavicle bone is located; hard; headache; Patient says they are feeling achiness; chills; This spontaneous case was reported by a consumer and describes the occurrence of EYE SWELLING (swollen right eye), VACCINATION SITE WARMTH (warm), VACCINATION SITE ERYTHEMA (red spot), LYMPHADENOPATHY (egg-sized lymph node on the right side of her neck where the clavicle bone is located) and VACCINATION SITE INDURATION (hard) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 02-Feb-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Feb-2021, the patient experienced HEADACHE (headache), MYALGIA (Patient says they are feeling achiness) and CHILLS (chills). On 03-Feb-2021, the patient experienced EYE SWELLING (swollen right eye), VACCINATION SITE WARMTH (warm), VACCINATION SITE ERYTHEMA (red spot), LYMPHADENOPATHY (egg-sized lymph node on the right side of her neck where the clavicle bone is located) and VACCINATION SITE INDURATION (hard). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency and CETIRIZINE HYDROCHLORIDE (ZYRTEC [CETIRIZINE HYDROCHLORIDE]) at an unspecified dose and frequency. At the time of the report, EYE SWELLING (swollen right eye), VACCINATION SITE WARMTH (warm), VACCINATION SITE ERYTHEMA (red spot), LYMPHADENOPATHY (egg-sized lymph node on the right side of her neck where the clavicle bone is located), VACCINATION SITE INDURATION (hard), HEADACHE (headache), MYALGIA (Patient says they are feeling achiness) and CHILLS (chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain, Vaccination site pruritus, Vaccination site rash
Clinical narrative: Left arm is itchy; Arm has red rash; Had a sore arm on site of administration; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (Left arm is itchy), VACCINATION SITE RASH (Arm has red rash) and VACCINATION SITE PAIN (Had a sore arm on site of administration) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Feb-2021, the patient experienced VACCINATION SITE PRURITUS (Left arm is itchy), VACCINATION SITE RASH (Arm has red rash) and VACCINATION SITE PAIN (Had a sore arm on site of administration). At the time of the report, VACCINATION SITE PRURITUS (Left arm is itchy), VACCINATION SITE RASH (Arm has red rash) and VACCINATION SITE PAIN (Had a sore arm on site of administration) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications reported by reporter. Treatment medication not reported.
Sex: F
Vaccine: COVID19
Symptoms: Flushing, Ocular hyperaemia, Vaccination complication
Clinical narrative: Vaccination adverse reaction; face flushing; bloodshot eye; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (Vaccination adverse reaction), FLUSHING (face flushing) and OCULAR HYPERAEMIA (bloodshot eye) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013M20A) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (Vaccination adverse reaction), FLUSHING (face flushing) and OCULAR HYPERAEMIA (bloodshot eye). At the time of the report, VACCINATION COMPLICATION (Vaccination adverse reaction), FLUSHING (face flushing) and OCULAR HYPERAEMIA (bloodshot eye) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Most recent FOLLOW-UP information incorporated above includes: On 05-Feb-2021: Added events (face flushing, bloodshot eyes). suspect drug batch lot provided.
Sex: F
Vaccine: COVID19
Symptoms: Feeling abnormal, Lethargy, Musculoskeletal stiffness, Myalgia, Peripheral swelling
Clinical narrative: swollen arm; really uncomfortable; Rash; bullseye like red blood area around the site of injection; lethargy; stiffness of the neck; itchiness on their body; muscle aches; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of LETHARGY (lethargy), MUSCULOSKELETAL STIFFNESS (stiffness of the neck), PRURITUS (itchiness on their body), PERIPHERAL SWELLING (swollen arm) and FEELING ABNORMAL (really uncomfortable) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011J20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history information was provided by the reporter.  Concomitant products included COLECALCIFEROL (VITAMIN D 3) for an unknown indication.    On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Jan-2021, the patient experienced LETHARGY (lethargy), MUSCULOSKELETAL STIFFNESS (stiffness of the neck), PRURITUS (itchiness on their body) and MYALGIA (muscle aches). On 23-Jan-2021, the patient experienced PERIPHERAL SWELLING (swollen arm), FEELING ABNORMAL (really uncomfortable), RASH (Rash) and VACCINATION SITE ERYTHEMA (bullseye like red blood area around the site of injection). The patient was treated with FEXOFENADINE HYDROCHLORIDE (ALLEGRA) for Rash, at an unspecified dose and frequency; DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for Adverse event, at an unspecified dose and frequency and HYDROCORTISONE for Adverse event, at an unspecified dose and frequency. On 16-Jan-2021, LETHARGY (lethargy), MUSCULOSKELETAL STIFFNESS (stiffness of the neck) and MYALGIA (muscle aches) had resolved. At the time of the report, PRURITUS (itchiness on their body), PERIPHERAL SWELLING (swollen arm), FEELING ABNORMAL (really uncomfortable), RASH (Rash) and VACCINATION SITE ERYTHEMA (bullseye like red blood area around the site of injection) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       On 23-Jun-2021, the patient experienced a delayed reaction with a swollen arm, intense itching and a bullseye like red blood area around the site of injection. Other concomitant medications included statins. Other treatment medications included lotion, steroid and ice. The patient felt an improvement of 90 percent after receiving hydrocortisone.
Sex: F
Vaccine: COVID19
Symptoms: Pruritus, Rash, Vaccination site erythema
Clinical narrative: swollen arm; really uncomfortable; Rash; bullseye like red blood area around the site of injection; lethargy; stiffness of the neck; itchiness on their body; muscle aches; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of LETHARGY (lethargy), MUSCULOSKELETAL STIFFNESS (stiffness of the neck), PRURITUS (itchiness on their body), PERIPHERAL SWELLING (swollen arm) and FEELING ABNORMAL (really uncomfortable) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011J20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history information was provided by the reporter.  Concomitant products included COLECALCIFEROL (VITAMIN D 3) for an unknown indication.    On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Jan-2021, the patient experienced LETHARGY (lethargy), MUSCULOSKELETAL STIFFNESS (stiffness of the neck), PRURITUS (itchiness on their body) and MYALGIA (muscle aches). On 23-Jan-2021, the patient experienced PERIPHERAL SWELLING (swollen arm), FEELING ABNORMAL (really uncomfortable), RASH (Rash) and VACCINATION SITE ERYTHEMA (bullseye like red blood area around the site of injection). The patient was treated with FEXOFENADINE HYDROCHLORIDE (ALLEGRA) for Rash, at an unspecified dose and frequency; DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for Adverse event, at an unspecified dose and frequency and HYDROCORTISONE for Adverse event, at an unspecified dose and frequency. On 16-Jan-2021, LETHARGY (lethargy), MUSCULOSKELETAL STIFFNESS (stiffness of the neck) and MYALGIA (muscle aches) had resolved. At the time of the report, PRURITUS (itchiness on their body), PERIPHERAL SWELLING (swollen arm), FEELING ABNORMAL (really uncomfortable), RASH (Rash) and VACCINATION SITE ERYTHEMA (bullseye like red blood area around the site of injection) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       On 23-Jun-2021, the patient experienced a delayed reaction with a swollen arm, intense itching and a bullseye like red blood area around the site of injection. Other concomitant medications included statins. Other treatment medications included lotion, steroid and ice. The patient felt an improvement of 90 percent after receiving hydrocortisone.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Lethargy, Myalgia, Vaccination site erythema, Vaccination site mass, Vaccination site pruritus
Clinical narrative: Felt lethargic; Hot and burning; Knot in the same arm of injection; Was itchy; Hives appeared on her left arm; Body aches; Red; This spontaneous case was reported by a consumer and describes the occurrence of LETHARGY (Felt lethargic), VACCINATION SITE WARMTH (Hot and burning), VACCINATION SITE MASS (Knot in the same arm of injection), VACCINATION SITE PRURITUS (Was itchy) and VACCINATION SITE URTICARIA (Hives appeared on her left arm) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039K20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 07-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Jan-2021, the patient experienced LETHARGY (Felt lethargic), VACCINATION SITE WARMTH (Hot and burning), VACCINATION SITE MASS (Knot in the same arm of injection), VACCINATION SITE PRURITUS (Was itchy), VACCINATION SITE URTICARIA (Hives appeared on her left arm), MYALGIA (Body aches) and VACCINATION SITE ERYTHEMA (Red). At the time of the report, LETHARGY (Felt lethargic), VACCINATION SITE WARMTH (Hot and burning), VACCINATION SITE MASS (Knot in the same arm of injection), VACCINATION SITE PRURITUS (Was itchy), VACCINATION SITE URTICARIA (Hives appeared on her left arm), MYALGIA (Body aches) and VACCINATION SITE ERYTHEMA (Red) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported. No treatment related information has been reported.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site urticaria, Vaccination site warmth
Clinical narrative: Felt lethargic; Hot and burning; Knot in the same arm of injection; Was itchy; Hives appeared on her left arm; Body aches; Red; This spontaneous case was reported by a consumer and describes the occurrence of LETHARGY (Felt lethargic), VACCINATION SITE WARMTH (Hot and burning), VACCINATION SITE MASS (Knot in the same arm of injection), VACCINATION SITE PRURITUS (Was itchy) and VACCINATION SITE URTICARIA (Hives appeared on her left arm) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039K20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 07-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Jan-2021, the patient experienced LETHARGY (Felt lethargic), VACCINATION SITE WARMTH (Hot and burning), VACCINATION SITE MASS (Knot in the same arm of injection), VACCINATION SITE PRURITUS (Was itchy), VACCINATION SITE URTICARIA (Hives appeared on her left arm), MYALGIA (Body aches) and VACCINATION SITE ERYTHEMA (Red). At the time of the report, LETHARGY (Felt lethargic), VACCINATION SITE WARMTH (Hot and burning), VACCINATION SITE MASS (Knot in the same arm of injection), VACCINATION SITE PRURITUS (Was itchy), VACCINATION SITE URTICARIA (Hives appeared on her left arm), MYALGIA (Body aches) and VACCINATION SITE ERYTHEMA (Red) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported. No treatment related information has been reported.
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Chills, Dizziness, Hyperhidrosis, Injection site pain
Clinical narrative: Woke up 3AM; Lightheaded; Sweating; Fever 104 F on chest and 101 F on the forehead; Chills; Pain all over the body; Nausea; Injection Site Hurt; This spontaneous case was reported by a health care professional and describes the occurrence of INSOMNIA (Woke up 3AM), DIZZINESS (Lightheaded), HYPERHIDROSIS (Sweating), PYREXIA (Fever 104 F on chest and 101 F on the forehead) and CHILLS (Chills) in a 53-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 013M20A and 024L204) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 09-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 03-Feb-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced INJECTION SITE PAIN (Injection Site Hurt). On 04-Feb-2021, the patient experienced INSOMNIA (Woke up 3AM), DIZZINESS (Lightheaded), HYPERHIDROSIS (Sweating), PYREXIA (Fever 104 F on chest and 101 F on the forehead), CHILLS (Chills), MYALGIA (Pain all over the body) and NAUSEA (Nausea). At the time of the report, INSOMNIA (Woke up 3AM), DIZZINESS (Lightheaded), HYPERHIDROSIS (Sweating), PYREXIA (Fever 104 F on chest and 101 F on the forehead), CHILLS (Chills), MYALGIA (Pain all over the body), NAUSEA (Nausea) and INJECTION SITE PAIN (Injection Site Hurt) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 04-Feb-2021, Body temperature: 104 (High) fever of 104 F on chest and 101 F on forehead.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were provided.  Treatment medication included muscle relaxer.
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Insomnia, Myalgia, Nausea, Pyrexia
Clinical narrative: Woke up 3AM; Lightheaded; Sweating; Fever 104 F on chest and 101 F on the forehead; Chills; Pain all over the body; Nausea; Injection Site Hurt; This spontaneous case was reported by a health care professional and describes the occurrence of INSOMNIA (Woke up 3AM), DIZZINESS (Lightheaded), HYPERHIDROSIS (Sweating), PYREXIA (Fever 104 F on chest and 101 F on the forehead) and CHILLS (Chills) in a 53-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 013M20A and 024L204) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 09-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 03-Feb-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced INJECTION SITE PAIN (Injection Site Hurt). On 04-Feb-2021, the patient experienced INSOMNIA (Woke up 3AM), DIZZINESS (Lightheaded), HYPERHIDROSIS (Sweating), PYREXIA (Fever 104 F on chest and 101 F on the forehead), CHILLS (Chills), MYALGIA (Pain all over the body) and NAUSEA (Nausea). At the time of the report, INSOMNIA (Woke up 3AM), DIZZINESS (Lightheaded), HYPERHIDROSIS (Sweating), PYREXIA (Fever 104 F on chest and 101 F on the forehead), CHILLS (Chills), MYALGIA (Pain all over the body), NAUSEA (Nausea) and INJECTION SITE PAIN (Injection Site Hurt) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 04-Feb-2021, Body temperature: 104 (High) fever of 104 F on chest and 101 F on forehead.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were provided.  Treatment medication included muscle relaxer.
Sex: M
Vaccine: COVID19
Symptoms: Headache, Pyrexia, SARS-CoV-2 test
Clinical narrative: Headache; Body was warm; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (Headache) and PYREXIA (Body was warm) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter.     On 20-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced HEADACHE (Headache) and PYREXIA (Body was warm). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, HEADACHE (Headache) and PYREXIA (Body was warm) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 25-Jan-2021, SARS-CoV-2 test: positive (Positive) Test result came (Positive) on 26-JAN-2021.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported.
Sex: M
Vaccine: COVID19
Symptoms: Body temperature, Pyrexia
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (has been on an off running a 101 fever) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 04-Feb-2021 at 11:00 AM, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Feb-2021, the patient experienced PYREXIA (has been on an off running a 101 fever). At the time of the report, PYREXIA (has been on an off running a 101 fever) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 04-Feb-2021, Body temperature: 101 (High) 101.         No concomitant medications were reported. No treatment related information has been reported.
Age: 44.0
Sex: M
Vaccine: COVID19
Symptoms: Eye inflammation, Eye pain, Lymphadenopathy, Ocular hyperaemia
Clinical narrative: Eye inflammation in both the eyes; Eyes got red; Pain in the back of right eye over to ear; Swollen lymph nodes; This spontaneous case was reported by a consumer and describes the occurrence of EYE INFLAMMATION (Eye inflammation in both the eyes), OCULAR HYPERAEMIA (Eyes got red), EYE PAIN (Pain in the back of right eye over to ear) and LYMPHADENOPATHY (Swollen lymph nodes) in a 44-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 19-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In 2021, the patient experienced EYE INFLAMMATION (Eye inflammation in both the eyes), OCULAR HYPERAEMIA (Eyes got red), EYE PAIN (Pain in the back of right eye over to ear) and LYMPHADENOPATHY (Swollen lymph nodes). The patient was treated with PARACETAMOL (TYLENOL) for Adverse event, at a dose of UNK dosage form. At the time of the report, EYE INFLAMMATION (Eye inflammation in both the eyes), OCULAR HYPERAEMIA (Eyes got red), EYE PAIN (Pain in the back of right eye over to ear) and LYMPHADENOPATHY (Swollen lymph nodes) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.  it was reported that, patient was prescribed to take Lotemax, and MRI (magnetic resonance imaging).
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Lymphadenopathy, Pain in extremity
Clinical narrative: Arm Soreness; Swollen Lymph Node; Fatigue; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Arm Soreness), LYMPHADENOPATHY (Swollen Lymph Node) and FATIGUE (Fatigue) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Feb-2021, the patient experienced PAIN IN EXTREMITY (Arm Soreness), LYMPHADENOPATHY (Swollen Lymph Node) and FATIGUE (Fatigue). On 05-Feb-2021, PAIN IN EXTREMITY (Arm Soreness), LYMPHADENOPATHY (Swollen Lymph Node) and FATIGUE (Fatigue) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter.  No treatment information was provided.   This case was linked to MOD21-021739, MOD21-021736, MOD21-021738, MOD-2021-021800 (Patient Link).
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site erythema, Injection site swelling
Clinical narrative: Raised area; Redness at the injection site; This spontaneous case was reported by a pharmacist and describes the occurrence of INJECTION SITE SWELLING (Raised area) and INJECTION SITE ERYTHEMA (Redness at the injection site) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 20-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced INJECTION SITE SWELLING (Raised area) and INJECTION SITE ERYTHEMA (Redness at the injection site). At the time of the report, INJECTION SITE SWELLING (Raised area) and INJECTION SITE ERYTHEMA (Redness at the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medication was reported.  No treatment medication was reported.
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site swelling, Vaccination site warmth
Clinical narrative: area was hot, a bit swollen, and angry.; Red from above the site of the injection site to all the way down to the elbow; Part of the area was raised and about the size of half a baseball.; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (area was hot, a bit swollen, and angry.), VACCINATION SITE ERYTHEMA (Red from above the site of the injection site to all the way down to the elbow) and VACCINATION SITE SWELLING (Part of the area was raised and about the size of half a baseball.) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027l20a) for COVID-19 vaccination.     No Medical History information was reported.    On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Jan-2021, the patient experienced VACCINATION SITE ERYTHEMA (Red from above the site of the injection site to all the way down to the elbow) and VACCINATION SITE SWELLING (Part of the area was raised and about the size of half a baseball.). On an unknown date, the patient experienced VACCINATION SITE WARMTH (area was hot, a bit swollen, and angry.). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) (oral) at an unspecified dose and frequency. At the time of the report, VACCINATION SITE WARMTH (area was hot, a bit swollen, and angry.) was resolving and VACCINATION SITE ERYTHEMA (Red from above the site of the injection site to all the way down to the elbow) and VACCINATION SITE SWELLING (Part of the area was raised and about the size of half a baseball.) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment details included Benadryl Spray, Steroid Cream, and Antibiotic.
Sex: F
Vaccine: COVID19
Symptoms: Chills, Cough, Dyspnoea, Fatigue, Feeding disorder
Clinical narrative: severe muscle fatigue; little cough; chills; little out of breath; couldn't eat; high fever over 102; body aches; extreme headache - intense; This spontaneous case was reported by a nurse and describes the occurrence of PYREXIA (high fever over 102), MYALGIA (body aches), HEADACHE (extreme headache - intense), FATIGUE (severe muscle fatigue) and COUGH (little cough) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 in March 2020. Concomitant products included VITAMINS NOS for an unknown indication.    On 08-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Jan-2021, the patient experienced PYREXIA (high fever over 102), MYALGIA (body aches), HEADACHE (extreme headache - intense), COUGH (little cough), CHILLS (chills), DYSPNOEA (little out of breath) and FEEDING DISORDER (couldn't eat). On 09-Jan-2021, the patient experienced FATIGUE (severe muscle fatigue). The patient was treated with PARACETAMOL (TYNELOL) at a dose of UNK, q6h. On 10-Jan-2021, PYREXIA (high fever over 102), MYALGIA (body aches), HEADACHE (extreme headache - intense), COUGH (little cough), CHILLS (chills), DYSPNOEA (little out of breath) and FEEDING DISORDER (couldn't eat) had resolved. On 12-Jan-2021, FATIGUE (severe muscle fatigue) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In January 2021, SARS-CoV-2 antibody test: positive (Positive) (took antibody test 3 weeks after the first dose and was Positive for antibodies).     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Sex: F
Vaccine: COVID19
Symptoms: Headache, Myalgia, Pyrexia, SARS-CoV-2 antibody test
Clinical narrative: severe muscle fatigue; little cough; chills; little out of breath; couldn't eat; high fever over 102; body aches; extreme headache - intense; This spontaneous case was reported by a nurse and describes the occurrence of PYREXIA (high fever over 102), MYALGIA (body aches), HEADACHE (extreme headache - intense), FATIGUE (severe muscle fatigue) and COUGH (little cough) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 in March 2020. Concomitant products included VITAMINS NOS for an unknown indication.    On 08-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Jan-2021, the patient experienced PYREXIA (high fever over 102), MYALGIA (body aches), HEADACHE (extreme headache - intense), COUGH (little cough), CHILLS (chills), DYSPNOEA (little out of breath) and FEEDING DISORDER (couldn't eat). On 09-Jan-2021, the patient experienced FATIGUE (severe muscle fatigue). The patient was treated with PARACETAMOL (TYNELOL) at a dose of UNK, q6h. On 10-Jan-2021, PYREXIA (high fever over 102), MYALGIA (body aches), HEADACHE (extreme headache - intense), COUGH (little cough), CHILLS (chills), DYSPNOEA (little out of breath) and FEEDING DISORDER (couldn't eat) had resolved. On 12-Jan-2021, FATIGUE (severe muscle fatigue) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In January 2021, SARS-CoV-2 antibody test: positive (Positive) (took antibody test 3 weeks after the first dose and was Positive for antibodies).     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Dry skin, Eye swelling, Rash, Skin tightness
Clinical narrative: Skin on her face and neck felt tight; Skin on her face and neck felt dry; Swollen eyes; Had a Rash; This spontaneous case was reported by a consumer and describes the occurrence of SKIN TIGHTNESS (Skin on her face and neck felt tight), DRY SKIN (Skin on her face and neck felt dry), EYE SWELLING (Swollen eyes) and RASH (Had a Rash) in a 51-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038K20A) for COVID-19 vaccination.     Concurrent medical conditions included Seasonal allergy and Allergy (The patient has outdoor allergy and takes allergy shots).    On 29-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 30-Jan-2021, the patient experienced SKIN TIGHTNESS (Skin on her face and neck felt tight), DRY SKIN (Skin on her face and neck felt dry), EYE SWELLING (Swollen eyes) and RASH (Had a Rash). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for Adverse event, at a dose of UNK dosage form. At the time of the report, SKIN TIGHTNESS (Skin on her face and neck felt tight), DRY SKIN (Skin on her face and neck felt dry), EYE SWELLING (Swollen eyes) and RASH (Had a Rash) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant information was not provided.  She took some Benadryl but it has not helped her symptoms much. She finds her symptoms more annoying than anything else.
Age: 81.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: soreness in knees and legs; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (soreness in knees and legs) in an 81-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011520A) for COVID-19 vaccination.     No medical history was provided by the reporter. .  Concomitant products included LOSARTAN, SIMVASTATIN and MULTIVITAMINS [VITAMINS NOS] for an unknown indication.    On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Feb-2021, the patient experienced PAIN IN EXTREMITY (soreness in knees and legs). At the time of the report, PAIN IN EXTREMITY (soreness in knees and legs) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment medication was not provided
Age: 21.0
Sex: F
Vaccine: COVID19
Symptoms: Ageusia, Anosmia, Headache, Nasal congestion, Nausea
Clinical narrative: Loss of smell; Tested positive for COVID 19after vaccine; Loss of taste; Nasal congestion; Runny nose; Headache; Nausea; Vomiting; Fever of 101 F; This spontaneous case was reported by a consumer and describes the occurrence of SARS-COV-2 TEST POSITIVE (Tested positive for COVID 19after vaccine), AGEUSIA (Loss of taste), ANOSMIA (Loss of smell), NASAL CONGESTION (Nasal congestion) and RHINORRHOEA (Runny nose) in a 21-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced SARS-COV-2 TEST POSITIVE (Tested positive for COVID 19after vaccine), AGEUSIA (Loss of taste), ANOSMIA (Loss of smell), NASAL CONGESTION (Nasal congestion), RHINORRHOEA (Runny nose), HEADACHE (Headache), NAUSEA (Nausea), VOMITING (Vomiting) and PYREXIA (Fever of 101 F). At the time of the report, SARS-COV-2 TEST POSITIVE (Tested positive for COVID 19after vaccine), AGEUSIA (Loss of taste), ANOSMIA (Loss of smell), NASAL CONGESTION (Nasal congestion), RHINORRHOEA (Runny nose), HEADACHE (Headache), NAUSEA (Nausea), VOMITING (Vomiting) and PYREXIA (Fever of 101 F) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 22-Jan-2021, SARS-CoV-2 test: positive (Positive) Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment medication was not provided.   Most recent FOLLOW-UP information incorporated above includes: On 21-Apr-2021: Add  COVID-19 PCR test. Add events headache, nausea, vomiting, loss of taste and loss of smell.
Age: 21.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Rhinorrhoea, SARS-CoV-2 test, SARS-CoV-2 test positive, Vomiting
Clinical narrative: Loss of smell; Tested positive for COVID 19after vaccine; Loss of taste; Nasal congestion; Runny nose; Headache; Nausea; Vomiting; Fever of 101 F; This spontaneous case was reported by a consumer and describes the occurrence of SARS-COV-2 TEST POSITIVE (Tested positive for COVID 19after vaccine), AGEUSIA (Loss of taste), ANOSMIA (Loss of smell), NASAL CONGESTION (Nasal congestion) and RHINORRHOEA (Runny nose) in a 21-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced SARS-COV-2 TEST POSITIVE (Tested positive for COVID 19after vaccine), AGEUSIA (Loss of taste), ANOSMIA (Loss of smell), NASAL CONGESTION (Nasal congestion), RHINORRHOEA (Runny nose), HEADACHE (Headache), NAUSEA (Nausea), VOMITING (Vomiting) and PYREXIA (Fever of 101 F). At the time of the report, SARS-COV-2 TEST POSITIVE (Tested positive for COVID 19after vaccine), AGEUSIA (Loss of taste), ANOSMIA (Loss of smell), NASAL CONGESTION (Nasal congestion), RHINORRHOEA (Runny nose), HEADACHE (Headache), NAUSEA (Nausea), VOMITING (Vomiting) and PYREXIA (Fever of 101 F) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 22-Jan-2021, SARS-CoV-2 test: positive (Positive) Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment medication was not provided.   Most recent FOLLOW-UP information incorporated above includes: On 21-Apr-2021: Add  COVID-19 PCR test. Add events headache, nausea, vomiting, loss of taste and loss of smell.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Fear, Herpes zoster, Pain, Pain in extremity, Rash
Clinical narrative: raised bumps under skin; scared of the possible 2nd vaccine side effects; Rash was on her torso, right thigh, lower back, love handles; not sleeping well; Shingles; "ghost pain" on her left thigh; weird type of pain/pain on her right side; sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (weird type of pain/pain on her right side), HERPES ZOSTER (Shingles), PAIN IN EXTREMITY ("ghost pain" on her left thigh), SKIN MASS (raised bumps under skin) and SLEEP DISORDER (not sleeping well) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Asthma and Seasonal allergy.    On 16-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Jan-2021, the patient experienced VACCINATION SITE PAIN (sore arm). On 30-Jan-2021, the patient experienced PAIN (weird type of pain/pain on her right side). On 02-Feb-2021, the patient experienced HERPES ZOSTER (Shingles), PAIN IN EXTREMITY ("ghost pain" on her left thigh), SLEEP DISORDER (not sleeping well) and RASH (Rash was on her torso, right thigh, lower back, love handles). On 06-Feb-2021, the patient experienced SKIN MASS (raised bumps under skin) and FEAR (scared of the possible 2nd vaccine side effects). At the time of the report, PAIN (weird type of pain/pain on her right side), HERPES ZOSTER (Shingles), PAIN IN EXTREMITY ("ghost pain" on her left thigh), SKIN MASS (raised bumps under skin), SLEEP DISORDER (not sleeping well), FEAR (scared of the possible 2nd vaccine side effects), RASH (Rash was on her torso, right thigh, lower back, love handles) and VACCINATION SITE PAIN (sore arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported. No treatment related information has been reported.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Skin mass, Sleep disorder, Vaccination site pain
Clinical narrative: raised bumps under skin; scared of the possible 2nd vaccine side effects; Rash was on her torso, right thigh, lower back, love handles; not sleeping well; Shingles; "ghost pain" on her left thigh; weird type of pain/pain on her right side; sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (weird type of pain/pain on her right side), HERPES ZOSTER (Shingles), PAIN IN EXTREMITY ("ghost pain" on her left thigh), SKIN MASS (raised bumps under skin) and SLEEP DISORDER (not sleeping well) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Asthma and Seasonal allergy.    On 16-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Jan-2021, the patient experienced VACCINATION SITE PAIN (sore arm). On 30-Jan-2021, the patient experienced PAIN (weird type of pain/pain on her right side). On 02-Feb-2021, the patient experienced HERPES ZOSTER (Shingles), PAIN IN EXTREMITY ("ghost pain" on her left thigh), SLEEP DISORDER (not sleeping well) and RASH (Rash was on her torso, right thigh, lower back, love handles). On 06-Feb-2021, the patient experienced SKIN MASS (raised bumps under skin) and FEAR (scared of the possible 2nd vaccine side effects). At the time of the report, PAIN (weird type of pain/pain on her right side), HERPES ZOSTER (Shingles), PAIN IN EXTREMITY ("ghost pain" on her left thigh), SKIN MASS (raised bumps under skin), SLEEP DISORDER (not sleeping well), FEAR (scared of the possible 2nd vaccine side effects), RASH (Rash was on her torso, right thigh, lower back, love handles) and VACCINATION SITE PAIN (sore arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported. No treatment related information has been reported.
Sex: F
Vaccine: COVID19
Symptoms: Hepatitis B immunisation
Clinical narrative: This spontaneous case was reported by a pharmacist and describes the occurrence of HEPATITIS B IMMUNISATION (received Hepatitis B vaccine 6 days before almost getting the Moderna COVID-19 vaccine) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Previously administered products included for an unreported indication: HEPATITIS B VACCINE.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Jan-2021, the patient experienced HEPATITIS B IMMUNISATION (received Hepatitis B vaccine 6 days before almost getting the Moderna COVID-19 vaccine). At the time of the report, HEPATITIS B IMMUNISATION (received Hepatitis B vaccine 6 days before almost getting the Moderna COVID-19 vaccine) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medications were not provided. Treatment information was not reported.
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site induration, Vaccination site swelling, Vaccination site warmth
Clinical narrative: has had swollen arm for more than 48 hours/it is red, hot and hard; has had swollen arm for more than 48 hours/it is red, hot and hard; has had swollen arm for more than 48 hours/it is red, hot and hard; has had swollen arm for more than 48 hours; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (has had swollen arm for more than 48 hours/it is red, hot and hard), VACCINATION SITE INDURATION (has had swollen arm for more than 48 hours/it is red, hot and hard), VACCINATION SITE ERYTHEMA (has had swollen arm for more than 48 hours/it is red, hot and hard) and VACCINATION SITE SWELLING (has had swollen arm for more than 48 hours) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE WARMTH (has had swollen arm for more than 48 hours/it is red, hot and hard), VACCINATION SITE INDURATION (has had swollen arm for more than 48 hours/it is red, hot and hard), VACCINATION SITE ERYTHEMA (has had swollen arm for more than 48 hours/it is red, hot and hard) and VACCINATION SITE SWELLING (has had swollen arm for more than 48 hours). At the time of the report, VACCINATION SITE WARMTH (has had swollen arm for more than 48 hours/it is red, hot and hard), VACCINATION SITE INDURATION (has had swollen arm for more than 48 hours/it is red, hot and hard), VACCINATION SITE ERYTHEMA (has had swollen arm for more than 48 hours/it is red, hot and hard) and VACCINATION SITE SWELLING (has had swollen arm for more than 48 hours) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported. No treatment related information has been reported.